BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19720796)

  • 1. Haptoglobin genotype and renal function decline in type 1 diabetes.
    Costacou T; Ferrell RE; Ellis D; Orchard TJ
    Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes.
    Williams KV; Cristaldi CL; Miller RG; Arena VC; Libman I; Huang Y; Becker DJ; Orchard TJ
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3828-3836. PubMed ID: 30099548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
    Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).
    Amin AP; Whaley-Connell AT; Li S; Chen SC; McCullough PA; Kosiborod MN;
    Am J Kidney Dis; 2013 Apr; 61(4 Suppl 2):S12-23. PubMed ID: 23507266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
    Molitch ME; Steffes M; Sun W; Rutledge B; Cleary P; de Boer IH; Zinman B; Lachin J;
    Diabetes Care; 2010 Jul; 33(7):1536-43. PubMed ID: 20413518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Costacou T; Ellis D; Fried L; Orchard TJ
    Am J Kidney Dis; 2007 Nov; 50(5):721-32. PubMed ID: 17954285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Orchard TJ; Sun W; Cleary PA; Genuth SM; Lachin JM; McGee P; Paterson AD; Raskin P; Anbinder Y; Levy AP;
    Diabetes; 2013 Sep; 62(9):3218-23. PubMed ID: 23761102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Jiang G; Luk AOY; Tam CHT; Xie F; Carstensen B; Lau ESH; Lim CKP; Lee HM; Ng ACW; Ng MCY; Ozaki R; Kong APS; Chow CC; Yang X; Lan HY; Tsui SKW; Fan X; Szeto CC; So WY; Chan JCN; Ma RCW;
    Kidney Int; 2019 Jan; 95(1):178-187. PubMed ID: 30415941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
    Colombo M; McGurnaghan SJ; Bell S; MacKenzie F; Patrick AW; Petrie JR; McKnight JA; MacRury S; Traynor J; Metcalfe W; McKeigue PM; Colhoun HM;
    Diabetologia; 2020 Mar; 63(3):636-647. PubMed ID: 31807796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.
    Gerber C; Cai X; Lee J; Craven T; Scialla J; Souma N; Srivastava A; Mehta R; Paluch A; Hodakowski A; Frazier R; Carnethon MR; Wolf MS; Isakova T
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):884-892. PubMed ID: 29798889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
    Bjornstad P; Pyle L; Kinney GL; Rewers M; Johnson RJ; Maahs DM; Snell-Bergeon JK
    J Diabetes Complications; 2017 Feb; 31(2):369-374. PubMed ID: 27368123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.
    Costacou T; Fried L; Ellis D; Orchard TJ
    Am J Kidney Dis; 2011 Oct; 58(4):565-73. PubMed ID: 21840097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal outcomes in patients with type 1 diabetes and macroalbuminuria.
    de Boer IH; Afkarian M; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B;
    J Am Soc Nephrol; 2014 Oct; 25(10):2342-50. PubMed ID: 24925722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
    Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of diabetic kidney disease.
    Reutens AT
    Med Clin North Am; 2013 Jan; 97(1):1-18. PubMed ID: 23290726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.